Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of D-0120 Tablets

Condition:   Hyperuricemia or Gout Intervention:   Drug: D-0120 Sponsor:   InventisBio Inc. Recruiting

Source: ClinicalTrials.gov - April 23, 2019 Category: Research Source Type: clinical trials